Central Nervous System-related Conditions and Associated Healthcare Resource Use Among Japanese nmCRPC Patients Based on Retrospective Claims Data

**Background:** Japanese patients with prostate cancer are typically treated with primary androgen deprivation therapy (ADT), most commonly administered as a combination of a luteinizing hormone-releasing hormone (LHRH) agonist and an antiandrogen (AA). Since LHRH agonists and AA therapy can be main...

Full description

Saved in:
Bibliographic Details
Main Authors: Dianne A. Ledesma, Jonathan L. Chua, Susan S.H. Tang, Xiu W. Lim
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2023-10-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.87550
Tags: Add Tag
No Tags, Be the first to tag this record!